Joan Sureda

Hospital Clínic de Barcelona

Papers

1

Total Citations

19

H-Index

1

About

Joan Sureda is a leading urologic oncologist whose research focuses on refining surgical outcomes in prostate cancer, particularly through the lens of robotic-assisted radical prostatectomy. His most cited work, a 2022 study on the effect of adverse surgical margins, has garnered 19 citations and fundamentally reshaped how clinicians interpret positive surgical margins (PSM). Rather than treating all PSMs as equivalent, Sureda demonstrated that specific margin characteristics—such as location, extent, and multifocality—carry distinct prognostic weights for biochemical recurrence (BCR). This nuanced approach allows for more personalized risk stratification, moving beyond a binary "positive or negative" framework to a granular assessment of recurrence risk. By identifying which margin features most strongly predict BCR, his work directly informs postoperative surveillance intensity and adjuvant therapy decisions. Sureda’s contributions bridge the gap between surgical technique and oncologic outcomes, offering actionable insights for urologists striving to balance cancer control with functional preservation. His research exemplifies how meticulous analysis of surgical pathology can translate into improved prognostic accuracy and patient counseling in the era of minimally invasive prostate cancer surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
19
Total Citations
19
Avg Citations/Paper
🏆 Most Cited Paper
The Effect of Adverse Surgical Margins on the Risk of Biochemical Recurrence after Robotic-Assisted Radical Prostatectomy
19 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Hospital Clínic de Barcelona

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago